Core One Labs Inc.

Core One Labs’ Akome Reveals Impressive Results for its Bio-Compounds Designed to Target Alzheimer’s and Parkinson’s, Showing Potential to Outperform Current Treatment Methods

Read Press Release: https://core1labs.com/company-news/core-one-labs-akome-reveals-impressive-results-for-its-psychedelic-bio-compounds-designed-to-target-alzheimers-and-parkinsons-showing-potential-to-outperform-current-treatm

Core One in Talks with Multiple Companies to Supply

Read Press Release:

Core One in Talks with Multiple Companies to Supply Psilocybin – Core One Labs Inc. Vancouver, British Columbia, Canada – May 5, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”) is pleased to announce that it is in discussions with several pharmaceutical laboratories and research organizations to supply the...